Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008613/
http://dx.doi.org/10.1007/s40278-022-13152-x
_version_ 1784687090693308416
collection PubMed
description
format Online
Article
Text
id pubmed-9008613
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90086132022-04-14 Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders Reactions Weekly Clinical Study Springer International Publishing 2022-04-16 2022 /pmc/articles/PMC9008613/ http://dx.doi.org/10.1007/s40278-022-13152-x Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title_full Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title_fullStr Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title_full_unstemmed Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title_short Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
title_sort hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008613/
http://dx.doi.org/10.1007/s40278-022-13152-x

Ejemplares similares